Is Fortis Malar Hospitals a good stock to invest in?

Fortis Malar Hospitals can be analyzed on the following key metrics - TTM P/E: 342.86 Sector P/E: 22.44 Dividend Yield: 0% D/E ratio: -

Fortis Malar Hospitals Share Price

Sector: Healthcare Facilities

Powered by

72.62 +0.21 (0.29%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 71.22

Today’s High 73.00

52 Week Low 51.01

52 Week High 98.70

Key Metrics

Market Cap (In Cr) 135.85
Beta 0.29
Div. Yield (%) 0
P/B 4.5
TTM P/E 342.86
Peg Ratio -
Sector P/E 22.44
Open Price 72
Prev Close 72.41

View All Metrics

Fortis Malar Hospitals Analysis

Price Analysis

1 Week

0.33%
3 Months

1.19%
6 Month

18.9%
YTD

19.84%
1 Year

8.72%

Risk Meter

47% Low risk
47% Moderate risk
47% Balanced Risk
47% High risk
47% Extreme risk

Fortis Malar Hospitals News

NTK had filed a claim in October 2023, seeking damages of 20 billion yen from Daiichi Sankyo for allegedly obstructing its efforts to complete its open offers to acquire shares in Indian hospital chain Fortis Healthcare and its subsidiary Fortis Malar Hospitals. (Bloomberg)

Premium

IHH Healthcare arm increases damages sought from Daiichi Sankyo to ₹11,800 crore

1 min read . 20 May 2025

Vuenow Infratech has declared an interim dividend of ₹0.50 per equity share.

Mint

Premium

Fortis Malar Hospitals, Aster DM Healthcare, shares to trade ex-dividend today

2 min read . 23 Apr 2024

Some companies are trading ex-dividend next week, while some will trade ex-bonus.

Premium

ICICI Securities, Aster DM Healthcare, others to trade ex-dividend next week

1 min read . 20 Apr 2024

TPG has proposed the current promoters, Malvinder and Shivinder Mohan Singh, who now own 67.5% stake in Fortis Healthcare, cede management control to the Fund. Photo: Ramesh Pathania/Mint

Premium

TPG bids Rs3,000 crore for Fortis Healthcare stake

3 min read . 16 Jan 2017

View More News

Fortis Malar Hospitals Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.41

Depreciation/ Amortization
0

Other Operating Expenses Total
1.73

Total Operating Expense
2.14

Operating Income
-2.14

Net Income Before Taxes
0.57

Net Income
0.39

Diluted Normalized EPS
0.21

Period
2024

Total Revenue
59.01

Selling/ General/ Admin Expenses Total
15.16

Depreciation/ Amortization
9.36

Other Operating Expenses Total
36.28

Total Operating Expense
22.36

Operating Income
36.65

Net Income Before Taxes
50.01

Net Income
45.32

Diluted Normalized EPS
4.09

Period
2023

Total Revenue
85.95

Selling/ General/ Admin Expenses Total
50.63

Depreciation/ Amortization
12.15

Other Operating Expenses Total
18.08

Total Operating Expense
93.53

Operating Income
-7.58

Net Income Before Taxes
-7.01

Net Income
-15.48

Diluted Normalized EPS
-8.26

Period
2022

Total Revenue
86.18

Selling/ General/ Admin Expenses Total
63.08

Depreciation/ Amortization
12.53

Other Operating Expenses Total
0.05

Total Operating Expense
95.27

Operating Income
-9.09

Net Income Before Taxes
-8.26

Net Income
-8.27

Diluted Normalized EPS
-4.43

Period
2021

Total Revenue
69.24

Selling/ General/ Admin Expenses Total
58.82

Depreciation/ Amortization
12.88

Other Operating Expenses Total
0.03

Total Operating Expense
81.61

Operating Income
-12.36

Net Income Before Taxes
-11.31

Net Income
-7.87

Diluted Normalized EPS
-6.57

Period
2020

Total Revenue
111.87

Selling/ General/ Admin Expenses Total
90.13

Depreciation/ Amortization
12.53

Other Operating Expenses Total
0.09

Total Operating Expense
127.1

Operating Income
-15.23

Net Income Before Taxes
-11.93

Net Income
-8.89

Diluted Normalized EPS
-4.72

Period
2019

Total Revenue
144.59

Selling/ General/ Admin Expenses Total
23.46

Depreciation/ Amortization
4.38

Other Operating Expenses Total
90.09

Total Operating Expense
151.33

Operating Income
-6.73

Net Income Before Taxes
2.79

Net Income
2.06

Diluted Normalized EPS
1.12

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Fortis Malar Hospitals Technical

Moving Average SMA

5 Day72.48
10 Day73.18
20 Day73.98

50 Day76.13
100 Day70.62
300 Day64.27

Fortis Malar Hospitals Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Aashka Hospitals
100
4
4.17
126.55
88.15
234

Lotus Eye Hospital And Institute
71.03
-0.65
-0.91
91
53.44
148.09

Fortis Malar Hospitals
72.62
0.21
0.29
98.7
51.01
135.85

Aspira Pathlab & Diagnostics
57
1
1.79
106.78
25
58.67

N G Industries
156
0.85
0.55
205.5
145
52

Fortis Malar Hospitals Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

15-May-25
Audited Results

03-Feb-25
Quarterly Results

05-Nov-24
Quarterly Results

22-Jul-24
Quarterly Results

17-May-24
Audited Results

12-Apr-24
Interim Dividend

08-Apr-24
Interim Dividend

05-Feb-24
Quarterly Results

06-Nov-23
Quarterly Results

02-Aug-23
Quarterly Results

Meeting Date
Announced on
Purpose

13-Jan-25
13-Dec-24
POM

31-Jul-24
10-Jul-24
AGM

05-Jan-24
04-Dec-23
POM

31-Jul-23
19-May-23
AGM

27-Jul-22
22-Jun-22
AGM

19-Feb-22
13-Jan-22
POM

29-Jul-21
29-Jun-21
AGM

12-Mar-21
08-Feb-21
POM

Announced on
Record Date
Ex-Dividend
Dividend Value

17-May-24
24-Jul-24
24-Jul-24
2.5

01-Apr-24
23-Apr-24
23-Apr-24
40

View All

Company Profile

ABOUT Fortis Malar Hospitals

Industry Healthcare Facilities
ISIN INE842B01015
BSE Code 523696

Fortis Malar Hospitals Limited is an India-based healthcare service provider. The Company operates a multi-specialty hospital in Chennai, which is engaged in providing super specialty and multi-specialty healthcare services. The Company monitors and evaluates its outcomes for various procedures and specialties, which include coronary artery bypass graft (CABG), percutaneous transluminal coronary angioplasty (PTCA), kidney transplant, cesarean section and total knee replacement. Its patient-reported outcomes measurement (PROM) lends the voice of the patient to the entire process and helps enhance patient engagement and experience. The Company’s subsidiary is Malar Stars Medicare Limited.

MANAGEMENT

Pradeep Malhotra Chief Financial Officer
Vinti Verma Company Secretary and Compliance Officer
Chandrasekar Ramasamy Whole-Time Director

FORTIS MALAR HOSPITALS SUMMARY

Fortis Malar Hospitals is trading 0.29% upper at Rs 72.62 as compared to its last closing price. Fortis Malar Hospitals has been trading in the price range of 73.00 & 71.22. Fortis Malar Hospitals has given 19.84% in this year & 0.33% in the last 5 days.

Fortis Malar Hospitals has TTM P/E ratio 342.86 as compared to the sector P/E of 22.44.

The company posted a net profit of 0.36 Crores in its last quarter.

Listed peers of Fortis Malar Hospitals include Aashka Hospitals (4.17%), Lotus Eye Hospital And Institute (-0.91%), Fortis Malar Hospitals (0.29%) etc.

Fortis Malar Hospitals has a 62.71% promoter holding & 37.29% public holding.

FAQs about Fortis Malar Hospitals

Fortis Malar Hospitals is trading at 72.62 as on 27 Jun, 2025 3:40:26 PM. This is 0.29% upper as compared to its previous closing price of 72.41

The market capitalization of Fortis Malar Hospitals is 135.85 Cr as on 27 Jun, 2025 3:40:26 PM.

The 52 wk high for Fortis Malar Hospitals is 98.70 whereas the 52 wk low is 51.01

Fortis Malar Hospitals can be analyzed on the following key metrics -

TTM P/E: 342.86
Sector P/E: 22.44
Dividend Yield: 0%
D/E ratio: -

Fortis Malar Hospitals reported a net profit of 0.39 Cr in 2025.

Fortis Malar Hospitals Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Fortis Malar Hospitals Share Price

Price Range

Key Metrics

Fortis Malar Hospitals Analysis

Fortis Malar Hospitals News

IHH Healthcare arm increases damages sought from Daiichi Sankyo to ₹11,800 crore

Fortis Malar Hospitals, Aster DM Healthcare, shares to trade ex-dividend today

ICICI Securities, Aster DM Healthcare, others to trade ex-dividend next week

TPG bids Rs3,000 crore for Fortis Healthcare stake

Fortis Malar Hospitals Financials

Forecast

Forecast

Forecast

Fortis Malar Hospitals Technical

Fortis Malar Hospitals Peers

Fortis Malar Hospitals Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Fortis Malar Hospitals

MANAGEMENT

FORTIS MALAR HOSPITALS SUMMARY

FAQs about Fortis Malar Hospitals

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue